Rosetta Genomics awarded US patent for method for treating malignancies The patent assignment, dated Mar. 5, is for "compositions and methods for the prevention and treatment of hematopoietic malignancies. The compositions are miRNAs and associated nucleic acids." Reference Link
News For ROSG From The Last 14 Days
Check below for free stories on ROSG the last two weeks.